150 related articles for article (PubMed ID: 15377338)
1. Expression and glycosylation of MUC1 in epidermolysis bullosa-associated and sporadic cutaneous squamous cell carcinomas.
Cooper HL; Cook IS; Theaker JM; Mallipeddi R; McGrath J; Friedmann P; Healy E
Br J Dermatol; 2004 Sep; 151(3):540-5. PubMed ID: 15377338
[TBL] [Abstract][Full Text] [Related]
2. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
Kivisaari AK; Kallajoki M; Mirtti T; McGrath JA; Bauer JW; Weber F; Königová R; Sawamura D; Sato-Matsumura KC; Shimizu H; Csikós M; Sinemus K; Beckert W; Kähäri VM
Br J Dermatol; 2008 Apr; 158(4):778-85. PubMed ID: 18284387
[TBL] [Abstract][Full Text] [Related]
3. Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of 7 cases and a review of the literature.
Yuen WY; Jonkman MF
J Am Acad Dermatol; 2011 Oct; 65(4):780-789. PubMed ID: 21624701
[TBL] [Abstract][Full Text] [Related]
4. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma.
Jang TJ
Yonsei Med J; 2002 Jun; 43(3):304-8. PubMed ID: 12089736
[TBL] [Abstract][Full Text] [Related]
6. Multiple Skin Squamous Cell Carcinomas in Junctional Epidermolysis Bullosa Due to Altered Laminin-332 Function.
Fortugno P; Condorelli AG; Dellambra E; Guerra L; Cianfarani F; Tinaburri L; Proto V; De Luca N; Passarelli F; Ricci F; Zambruno G; Castiglia D
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093196
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Kivisaari AK; Kallajoki M; Ala-aho R; McGrath JA; Bauer JW; Königová R; Medvecz M; Beckert W; Grénman R; Kähäri VM
Br J Dermatol; 2010 Oct; 163(4):726-35. PubMed ID: 20586780
[TBL] [Abstract][Full Text] [Related]
8. Reduced human mismatch repair protein expression in the development of precancerous skin lesions to squamous cell carcinoma.
Liang SB; Furihata M; Takeuchi T; Sonobe H; Ohtsuki Y
Virchows Arch; 2001 Nov; 439(5):622-7. PubMed ID: 11764381
[TBL] [Abstract][Full Text] [Related]
9. Epidermolysis-Bullosa-Associated Squamous Cell Carcinomas Support an Immunosuppressive Tumor Microenvironment: Prospects for Immunotherapy.
Rafei-Shamsabadi D; Scholten L; Lu S; Castiglia D; Zambruno G; Volz A; Arnold A; Saleva M; Martin L; Technau-Hafsi K; Meiss F; von Bubnoff D; Has C
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275911
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the clinical, histological, and biological characteristics of squamous cell carcinomas in areas previously treated with photodynamic therapy.
Gracia Cazaña T; Salazar N; Vera-Álvarez J; González S; Juarranz A; Gilaberte Y
Eur J Dermatol; 2017 Dec; 27(6):627-634. PubMed ID: 29141833
[TBL] [Abstract][Full Text] [Related]
11. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
[TBL] [Abstract][Full Text] [Related]
12. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.
Fine JD; Johnson LB; Weiner M; Li KP; Suchindran C
J Am Acad Dermatol; 2009 Feb; 60(2):203-11. PubMed ID: 19026465
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa. A report of 4 patients with 17 primary cutaneous malignancies.
Newman C; Wagner RF; Tyring SK; Spigel GT
J Dermatol Surg Oncol; 1992 Apr; 18(4):301-5. PubMed ID: 1560154
[TBL] [Abstract][Full Text] [Related]
14. Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.
Condorelli AG; Dellambra E; Logli E; Zambruno G; Castiglia D
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739489
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis and cellular proliferation in human epidermal squamous cell neoplasia.
Makino T; Tatebe S; Goto A; Mihara M; Ito H
J Cutan Pathol; 1998 Mar; 25(3):136-42. PubMed ID: 9550311
[TBL] [Abstract][Full Text] [Related]
16. [Expression of promyelocytic leukaemia protein in Bowen's disease, skin squamous cell carcinoma and basal cell carcinoma].
Wang Q; Ma H; Wang S; Ma Y; Zou X; Li R
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1075-7. PubMed ID: 23895857
[TBL] [Abstract][Full Text] [Related]
17. Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features.
An X; Xu G; Yang L; Wang Y; Li Y; McHepange UO; Shen G; Tu Y; Tao J
J Dermatol; 2014 Jan; 41(1):76-83. PubMed ID: 24354513
[TBL] [Abstract][Full Text] [Related]
18. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
Hughes JH; Robinson RA
Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
[TBL] [Abstract][Full Text] [Related]
19. Nestin expression in Bowen's disease and Bowen's carcinoma associated with human papillomavirus.
Mii S; Amoh Y; Tanabe K; Kitasato H; Sato Y; Katsuoka K
Eur J Dermatol; 2011; 21(4):515-9. PubMed ID: 21700534
[TBL] [Abstract][Full Text] [Related]
20. Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis.
Rodeck U; Uitto J
J Invest Dermatol; 2007 Oct; 127(10):2295-6. PubMed ID: 17853916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
